Abstract
Purpose
The preimplantation genetic testing for monogenic defects (PGT-M) is a beneficial strategy for the patients suffering from a Mendelian disease, which could protect their offspring from inheriting the disease. The purpose of this study is to report the effectiveness of PGT-M based on karyomapping for three cases of dynamic mutation diseases with trinucleotide repeat expansion.
Methods
PGT-M was carried out on three couples, whose family members were diagnosed with Huntington’s disease or spinocerebellar ataxias 2 or 12. The whole genome amplification was obtained using the multiple displacement amplification (MDA) method. Then, karyomapping was performed to detect the allele that is carrying the trinucleotide repeat expansion using single nucleotide polymorphism (SNP) linkage analyses, and the copy number variations (CNVs) of the embryos were also identified. Prenatal diagnosis was performed to validate the accuracy of PGT-M.
Results
PGT-M was successfully performed on the three couples, and they accepted the transfers of euploid blastocysts without the relevant pathogenic allele. The clinical pregnancies were acquired and the prenatal diagnosis of the three families confirmed the effectiveness of karyomapping. The three born babies were healthy and free of the pathogenic alleles HTT, ATXN2, or PPP2R2B corresponding to Huntington’s disease, spinocerebellar ataxias 2 or 12, respectively.
Conclusion
This study shows that karyomapping is a highly powerful and efficient approach for dynamic mutation detection in preimplantation embryos. In this work, we first report the birth of healthy babies that are free of the pathogenic gene for dynamic mutation diseases in patients receiving PGT-M by karyomapping.
Similar content being viewed by others
References
Kay C, Hayden MR, Leavitt BR. Epidemiology of Huntington disease. Handb Clin Neurol. 2017;144:31–46.
Ghosh R, Tabrizi SJ. Clinical features of Huntington’s disease. Adv Exp Med Biol. 2018;1049:1–28.
Group THsDCR. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72:971–83.
Ziihlke C, Rless O, Bockel B, Lange H, Thies U. Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum Mol Genet. 1993;2:2063–7.
Soong BW, Morrison PJ. Spinocerebellar ataxias. Handb Clin Neurol. 2018;155:143–74.
Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia a systematic review of prevalence studies. Neuroepidemiology. 2014;42:174–83.
Sermon K, Goossens V, Seneca S, Lissens W, Vos AD, Vandervorst M, et al. Preimplantation diagnosis for Huntington’s disease (HD) clinical application and analysis of the HD expansion in affected embryos. Prenat Diagn. 1998;18:1427–36.
Sermon K, Seneca S, Vanderfaeillie A, Lissens W. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG. Prenat Diagn. 1999;19:1223–30.
Sermon K, Seneca S, Rycke MD, Goossens V. PGD in the lab for triplet repeat diseases-myotonic dystrophy, Huntington’s disease and fragile-X syndrome. Mol Cell Endocrinol. 2001;183:S77–85.
Moutou C, Gardes N, Viville S. New tools for preimplantation genetic diagnosis of Huntington’s disease and their clinical applications. Eur J Hum Genet. 2004;12:1007–14.
Van Rij MC, De Rademaeker M, Moutou C, Dreesen JC, De Rycke M, Liebaers I, et al. Preimplantation genetic diagnosis (PGD) for Huntington’s disease: the experience of three European centres. Eur J Hum Genet. 2012;20:368–75.
Pecina A, Lozano Arana MD, Garcia-Lozano JC, Borrego S, Antinolo G. One-step multiplex polymerase chain reaction for preimplantation genetic diagnosis of Huntington disease. Fertil Steril. 2010;93:2411–2.
Kieffer E, Nicod JC, Gardes N, Kastner C, Becker N, Celebi C, et al. Improving preimplantation genetic diagnosis for fragile X syndrome: two new powerful single-round multiplex indirect and direct tests. Eur J Hum Genet. 2016;24:221–7.
Moutou C, Nicod JC, Gardes N, Viville S. Birth after pre-implantation genetic diagnosis (PGD) of spinocerebellar ataxia 2 (Sca2). Prenat Diagn. 2008;28:126–30.
Lasken RS. Genomic DNA amplification by the multiple displacement amplification (MDA) method. Biochem Soc Trans. 2009;37:450–3.
Buijsen RAM, Toonen LJA, Gardiner SL, van Roon-Mom WMC. Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias. Neurotherapeutics. 2019;16:263–86.
Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47:651–8.
Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med. 2009;15:577–83.
Fragouli E, Alfarawati S, Spath K, Jaroudi S, Sarasa J, Enciso M, et al. The origin and impact of embryonic aneuploidy. Hum Genet. 2013;132:1001–13.
Huang L, Ma F, Chapman A, Lu S, Xie XS. Single-cell whole-genome amplification and sequencing: methodology and applications. Annu Rev Genomics Hum Genet. 2015;16:79–102.
Yan L, Huang L, Xu L, Huang J, Ma F, Zhu X, et al. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses. Proc Natl Acad Sci U S A. 2015;112:15964–49.
Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med. 2014;16:838–45.
Konstantinidis M, Prates R, Goodall NN, Fischer J, Tecson V, Lemma T, et al. Live births following karyomapping of human blastocysts: experience from clinical application of the method. Reprod BioMed Online. 2015;31:394–403.
Natesan SA, Handyside AH, Thornhill AR, Ottolini CS, Sage K, Summers MC, et al. Live birth after PGD with confirmation by a comprehensive approach (karyomapping) for simultaneous detection of monogenic and chromosomal disorders. Reprod BioMed Online. 2014;29:600–5.
Ben-Nagi J, Wells D, Doye K, Loutradi K, Exeter H, Drew E, et al. Karyomapping: a single centre’s experience from application of methodology to ongoing pregnancy and live-birth rates. Reprod BioMed Online. 2017;35:264–71.
Sermon K. Novel technologies emerging for preimplantation genetic diagnosis and preimplantation genetic testing for aneuploidy. Expert Rev Mol Diagn. 2017;17:71–82.
Treff NR, Fedick A, Tao X, Devkota B, Taylor D, Scott RT Jr. Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil Steril. 2013;99:1377–84.
Van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The third revolution in sequencing technology. Trends Genet. 2018;34:666–81.
Acknowledgments
We thank the families for taking part and everybody involved in the research for their contributions.
Funding
This work was supported by National Key R&D Program of China (2019YFA0110900 to Yingpu Sun and Jiawei Xu, and 2019YFA0802200 to Jiawei Xu), National Natural Science Foundation of China (31870817 to Jiawei Xu.), Scientific and Technological Innovation Talent Project of Universities of Henan Province (20HASTIT045 to Jiawei Xu), and Henan Provincial Obstetrical and Gynecological Diseases (Reproductive Medicine) Clinical Research Center (to Yingpu Sun and Jiawei Xu).
Author information
Authors and Affiliations
Contributions
Y.S. and J.X designed the study; G.Y., S.S., W.S., and H.J. performed embryo culture and biopsy; H.S. and G.L. collected the data; W.N., Y.L., and D.S. analyzed the data; D.S. drafted the manuscript; and J.X. revised it.
Corresponding authors
Ethics declarations
All couples signed informed consent forms for ICSI treatment, PGT, cryopreservation, thawing, and transfer of embryos. The protocols for this study were evaluated and approved by the Internal Review Board of The First Affiliated Hospital of Zhengzhou University.
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplemental Figure 1
Copy number variations (CNVs) of case 2 and case 3. The CNVs of case 2 are shown by the B-allele and Log R charts in a and b: a. Del(5)(pter-p13.1) in embryo E7; b. Transferred euploid embryo E3. The CNVs of case 3 are displayed in c-g: c. Del(22)(q13.1-q13.2) in embryo E1; d. 47, XXY in embryo E2; e. Monosomy of the 14th chromosome in embryo E4; f. Multiple trisomy of the chromosomes 2, 5, 10, 11, 14, 15 and 16 in embryo E5; g. Transferred euploid embryo E11. (PNG 3305 kb)
ESM 2
(DOCX 34 kb)
Rights and permissions
About this article
Cite this article
Shi, D., Xu, J., Niu, W. et al. Live births following preimplantation genetic testing for dynamic mutation diseases by karyomapping: a report of three cases. J Assist Reprod Genet 37, 539–548 (2020). https://doi.org/10.1007/s10815-020-01718-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-020-01718-5